BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Harvard Business School
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076827

« Back to Dashboard

NDA 076827 describes VINORELBINE TARTRATE, which is a drug marketed by Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in ten NDAs. It is available from four suppliers. Additional details are available on the VINORELBINE TARTRATE profile page.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
Summary for 076827
Ingredient:vinorelbine tartrate
Formulation / Manufacturing:see details
Pharmacology for NDA: 076827
Ingredient-typeVinca Alkaloids
Suppliers and Packaging for NDA: 076827
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827 ANDA Hospira, Inc. 61703-341 61703-341-09 1 VIAL, SINGLE-USE in 1 CARTON (61703-341-09) > 5 mL in 1 VIAL, SINGLE-USE
VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827 ANDA Hospira, Inc. 61703-341 61703-341-06 1 VIAL, SINGLE-USE in 1 CARTON (61703-341-06) > 1 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Jun 2, 2005TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Express Scripts
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.